{"data":{"id":"us-ut/utah-code-58-38a-203","jurisdiction":"us-ut","citation":"Utah Code § 58-38a-203","heading":"Duties of the committee.","body":"(1) The committee serves as a consultative and advisory body to the Legislature regarding:\n(a) the movement of a controlled substance from one schedule or list to another;\n(b) the removal of a controlled substance from any schedule or list; and\n(c) the designation of a substance as a controlled substance and the placement of the substance in a designated schedule or list.\n(2) On or before September 30 of each year, the committee shall submit to the Health and Human Services Interim Committee a written report:\n(a) describing any substances recommended by the committee for scheduling, rescheduling, listing, or deletion from the schedules or list by the Legislature; and\n(b) stating the reasons for the recommendation.\n(3) In advising the Legislature regarding the need to add, delete, relist, or reschedule a substance, the committee shall consider:\n(a) the actual or probable abuse of the substance, including:\n(i) the history and current pattern of abuse both in Utah and in other states;\n(ii) the scope, duration, and significance of abuse;\n(iii) the degree of actual or probable detriment to public health which may result from abuse of the substance; and\n(iv) the probable physical and social impact of widespread abuse of the substance;\n(b) the biomedical hazard of the substance, including:\n(i) its pharmacology, including the effects and modifiers of the effects of the substance;\n(ii) its toxicology, acute and chronic toxicity, interaction with other substances, whether controlled or not, and the degree to which it may cause psychological or physiological dependence; and\n(iii) the risk to public health and the particular susceptibility of segments of the population;\n(c) whether the substance is an immediate precursor, as defined in Section 58-37-101, of a substance that is currently a controlled substance;\n(d) the current state of scientific knowledge regarding the substance, including whether there is any acceptable means to safely use the substance under medical supervision;\n(e) the relationship between the use of the substance and criminal activity, including whether:\n(i) persons engaged in illicit trafficking of the substance are also engaged in other criminal activity;\n(ii) the nature and relative profitability of manufacturing or delivering the substance encourages illicit trafficking in the substance;\n(iii) the commission of other crimes is one of the recognized effects of abuse of the substance; and\n(iv) addiction to the substance relates to the commission of crimes to facilitate the continued use of the substance;\n(f) whether the substance has been scheduled by other states; and\n(g) whether the substance has any accepted medical use in treatment in the United States.\n(4) The committee's duties under this chapter do not include tobacco products as defined in Section 59-14-102 or alcoholic beverages as defined in Section 32B-1-102.","path":["Title 58 Occupations and Professions","Chapter 58-38a Controlled Substances Advisory Committee Act","Part 58-38a-2 Controlled Substances Advisory Committee"],"source_url":"https://le.utah.gov/xcode/Title58/Chapter38a/58-38a-S203.html","current_through":"2026 General Session","vintage":"","retrieved_at":"2026-09-03T11:34:33Z","sha256":"eb04a4b1756e9a69ac72b618d679ae057185a3b57a91b1a1c748f555f8fc4702","source_id":"us-ut","stale":false,"prev":"us-ut/utah-code-58-38a-202","next":"us-ut/utah-code-58-38a-204"},"notice":"GroundRules: Original legal text. Not legal advice."}